Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DIC20P
|
|||
Drug Name |
HB-AdMSC
|
|||
Drug Type |
Cell therapy
|
|||
Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 2 | [1] | |
Company |
Hope Biosciences
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04362189) Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.